Hannah V. M.
- Country
- Belgium
- Department
- Gastroenterology and Hepatology
Research Overview
Data & Insights
Has run more than one trial at 10 of 86 partner sites.
Specializations
Hepatology & Biliary Disorders
Focused on investigating therapeutic approaches for Primary Sclerosing Cholangitis (PSC), a progressive liver condition affecting the bile ducts. The investigator explores innovative treatment options to address this challenging hepatobiliary disorder.
- Chronic liver diseases
- Biliary tract disorders
- Autoimmune hepatic conditions
Specializes in evaluating novel therapeutic compounds targeting bile acid metabolism and hepatic inflammation.
Clinical Therapeutics
Conducts research on novel oral therapeutic agents for chronic liver conditions, with particular emphasis on investigating film-coated tablet formulations for improved patient treatment outcomes.
- Drug safety assessment
- Treatment tolerability
- Open-label studies
Expertise in evaluating the clinical application of emerging pharmaceutical compounds in hepatology.
Gastroenterology
Specializes in the intersection of hepatobiliary and gastrointestinal disorders, focusing on conditions that affect both liver function and digestive health.
- Cholestatic liver diseases
- Bile duct disorders
- Inflammatory conditions
Investigates the relationship between biliary system disorders and overall gastrointestinal health.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.